Gavage-Related Reflux in Rats:Identification, Pathogenesis, and Toxicological Implications (Review)

Toxicologic Pathology

Volumn 39, Issue 2, 2011, Pages 348-360

  Damsch, Siegrid ^a   Eichenbaum, Gary ^b   Tonelli, Alfred ^b   Lammens, Lieve ^a   Bulck, Kathleen Van Den ^a   Feyen, Bianca ^a   Vandenberghe, John ^a   Megens, Anton ^a   Knight, Elaine ^b   Kelley, Michael ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

dyspnea; gastric emptying; gavage; nasal cavity; rat; reflux

Indexed keywords

BARIUM SULFATE; CEFACLOR; HYPERTONIC SOLUTION; MACROGOL 400; POTASSIUM PERFLUOROBUTANESULFONATE; SODIUM ALPHA OLEFIN SULFONATE; SULFONIC ACID DERIVATIVE; UBIQUINONE; UNCLASSIFIED DRUG;

ARTICLE; ESOPHAGUS ULCER; FEEDING; GASTROESOPHAGEAL REFLUX; HISTIOCYTOSIS; HISTOPATHOLOGY; LARYNX INJURY; LUNG EDEMA; LUNG HEMORRHAGE; NONHUMAN; NOSE CAVITY; PATHOGENESIS; PHYSICAL CHEMISTRY; PNEUMONIA; PRIORITY JOURNAL; RHINITIS; RISK FACTOR; ROOT CAUSE ANALYSIS; SINUSITIS; SQUAMOUS CELL METAPLASIA; STOMACH CONTENT; STOMACH EMPTYING; STOMACH ULCER; STOMACH VOLUME; TOXICOLOGY; TRACHEA INJURY;

ADMINISTRATION, ORAL; ANIMALS; DYSPNEA; ENTERAL NUTRITION; GASTRIC ACID; GASTRIC EMPTYING; GASTROESOPHAGEAL REFLUX; NASAL CAVITY; RATS; RISK FACTORS;

RATTUS;

EID: 79954465651     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310388431     Document Type: Article

References (44)

1. Blackwood A. D. Salter J. Dettmar P. W. Chaplin M. F. (2000). Dietary fibre, physicochemical properties and their relationship to health. J Royal Soc Promot Health 120, 242–47.
2. Boeckxstaens G. E. (2007). Review article: The pathophysiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 26, 149–60.
3. Bozkurt A. Deniz M. Yegen B. C. (2000). Cefaclo, a cephalosporin antibiotic, delays gastric emptying rate by a CCK-A receptor-mediated mechanism in the rat. Br J Pharmacol 131, 399–404.
4. Cakir B. Kasimay O. Devseren E. Yegen B.C. (2007). Leptin inhibits gastric emptying in rats: Role of CCK receptors and vagal afferent fibers. Physiol Res 56, 315–22.
5. Capasso R. Borrelli F. Aviello G. Capasso F. Izzo A. A. (2008). Inhibitory effect of the herbal antidepressant St. John’s wort (Hypericum perforatum) on rat gastric motility. Naunyn Schmiedebergs Archiv Pharmacol 376, 407–14.
6. Conybeare G. Leslie G. B. (1988). Improved oral dosing technique for rats. J Pharmacol Methods 19, 109–16.
7. Coskun T. Bozkurt A. Alican I. Ozkutlu U. Kurtel H. Yegen B. C. (1997). Pathways mediating CRF-induced inhibition of gastric emptying in rats. Reg Pept 69, 113–20.
8. Damsch S. Eichenbaum G. Looszova A. Lammens L. Feyen B. Van den Bulck K. Megens A. Knight E. Kelley M. Tonelli A. (in press). Unexpected nasal changes in rats related to reflux after gavage dosing. Toxicol Pathol. 2010 (in press).
9. Damsch S. Eichenbaum G. Looszova A. Lammens L. Vandenberghe J. Van den Bulck K. Megens A. Feyen B. Knight E. Kelley M. Tonelli A. (2009). Unexpected nasal changes after oral gavage in rats and the relation to delayed gastric emptying. Presented at the 7th ESTP Congress, The Hague, The Netherlands, September 15–18, 2009.
10. De Jonghe S. Lammens L. Raoof A. Steemans K. Broeckaert F. Verbeeck J. Van Goethem F. Hanton G. (2009). Lethal rhinitis/sinusitis in rodents by aspiration of formulation in gavage studies: Importance of evaluation of the nose. Poster presented at the 6th European Congress of Toxicologic Pathology, Edinburgh/Scotland, 2008. Exp Toxicol Pathol 61, 410.
11. Diehl K. H. Hull R. Morton D. Pfister R. Rabemampianina Y. Smith D. Vidal J. M. van de Vorstenbosch C. (2001). A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21, 15–23.
12. Dong H. Loomis C. W. Bieger D. (2001). Vagal afferent input determines the volume dependence of rat esophageal motility patterns. Am J Physiol Gastrointest Liver Physiol 281, G44–G53.
13. Edelbroek M. Horowitz M. Dent J. Sun W.M. Malbert C. Smout A. Akkermans L. (1994). Effects of duodenal distention on fasting and postprandial antropyloroduodenal motility in humans. Gastroenterology 106, 583–92.
14. Eichenbaum G. Damsch S. Looszova A. Vandenberghe J. Van den Bulck K. Megens A. Knight E. Hillsamer V. Feyen B. Kelley M. Tonelli A. Lammens L. Impact of the gavage dosing procedure on adverse respiratory effects and mortality in rat toxicity studies. J Appl Toxicol. In press.
15. Galligan J. J. Vanner S. (2005). Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 17, 643–53.
16. Gaude G. S. (2009). Pulmonary manifestations of gastroesophageal reflux disease. Ann Thorac Med 4, 115–23.
17. Horn C. C. (2008). Why is the neurobiology of nausea and vomiting so important? Appetite 50, 430–34.
18. Horn C. C. (2009). Brain Fos expression induced by the chemotherapy agent cisplatin in the rat is partially dependent on an intact abdominal vagus. Auton Neurosci 148, 76–82.
19. Jecker P. Orloff L. A. Mann W. J. (2005). Extraesophageal reflux and upper aerodigestive tract diseases. J Otorhinolaryngol Relat Spec 67, 185–91.
20. Johnson D. A. (2008). Medical therapy of reflux laryngitis. J Clin Gastroenterol 42, 589–93.
21. King G. L. (1990). Animal models in the study of vomiting. Can J Physiol Pharmacol 68, 260–68.
22. Kittel B. Ruehl-Fehlert C. Morawietz G. Klapwijk J. Elwell M. R. Lenz B. O’Sullivan M. G. Roth D. R. Wadsworth P. F. (2004). Revised guides for organ sampling and trimming in rats and mice–Part 2 (joint publication of the RITA and NACAD groups). Exp Toxicol Pathol 55, 413–31.
23. Lieder P. H. Chang S. C. York R. G. Butenhoff J. L. (2009). Toxicological evaluation of potassium perfluorobutanesulfonate in a 90-day oral gavage study with Sprague Dawley rats. Toxicology 255, 45–52.
24. Mard S. A. Gharib Naseri M. K. Badavi M. (2009). Gastric secretions affected by esophageal distention in the rat. J Gastroenterol 44, 132–38.
25. Maronpot R. (2009). Xenobiotic-induced rodent tumors of questionable relevance to human cancer risk. Presented at the 7th European Congress of Toxicologic Pathology 2009, The Hague, The Netherlands.
26. Martinez V. Wang L. Rivier J. E. Vale W. Tache Y. (2002). Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: Role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 301, 611–17.
27. Megale S. R. Scanavini A. B. Andrade E. C. Fernandes M. I. Anselmo-Lima W. T. (2006). Gastroesophageal reflux disease: its importance in ear, nose, and throat practice. Int J Pediatr Otorhinolaryngol 70, 81.
28. Megens A. (1991). General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine and cisapride. Arzneimittel-Forschung 41, 631–34.
29. Montedonico S. Godoy J. Mate A. Possogel A. K. Diez-Pardo J. A. Tovar J. A. (1999). Muscular architecture and manometric image of gastroesophageal barrier in the rat. Dig Dis Sci 44, 2449–55.
30. Montedonico S. Diez-Pardo J. A. Tovar J. A. (1999). Gastro-esophageal reflux after combined lower esophageal sphincter and diaphragmatic crural sling inactivation in the rat. Dig Dis Sci 44, 2283–89.
31. Nguyen N. Q. Holloway R. H. (2005). Recent developments in esophageal motor disorders. Curr Opin Gastroenterol 21, 478–84.
32. Pauwels A. Blondeau K. Dupont L. Sifrim D. (2009). Cough and gastroesophageal reflux: From the gastroenterologist end. Pulmon Pharmacol Ther 22, 35–38.
33. Peters S. A. Hultin L. (2008). Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in rat. J Pharmacokinet Pharmacodyn 35, 1–30.
34. Poelmans J. Feenstra L. Tack J. (2006). Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms. Dig Dis Sci 51, 282–88.
35. E.E.M., Quigley, Review article: Gastric emptying in functional gastrointestinal disorders, Aliment Pharmacol Ther, (2004), 20, 7, 56-60
36. Richter J. E. (2005). Extraoesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Therap 22 (Suppl 1), 70–80.
37. Samson M. Szarka L. A. Camilleri M. Vella A. Zinsmeister A. R. Rizza R. A. (2000). Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol 278, G946–51.
38. Shillabeer G. Davison J. S. (1987). Proglumide, a cholecystokinine antagonist, increases gastric emptying in rats. Am J Physiol 252, R353–60.
39. Sifrim D. Tack J. Lerut T. Janssens J. (2000). Transient lower esophageal sphincter relaxations and esophageal body muscular contractile response in reflux esophagitis. Dig Dis Sci 45, 1293–300.
40. Stadler J. C. Delker D. A. Malley L. A. Frame S. R. Everds N. E. Mylchreest E. Munley S. M. Loveless S. E. Buck R. C. (2008). Subchronic, reproductive, and developmental toxicity of a fluorotelomer-based urethane polymeric product. Drug Chem Toxicol 31, 317–37.
41. Takeda N. Hasegawa S. Morita M. Matsunaga T. (1993). Pica in rats is analogous to emesis: An animal model in emesis research. Pharmacol Biochem Behav 45, 817–21.
42. Will L. A. Elininger J. R. Donham K. J. (1979). Regurgitation and choke in rats. Lab Anim Sci 29, 360–63.
43. Williams K. D. Maneke J. D. AbdelHameed M. Hall R. L. Palmer T. H. Kitano M. Hidaka T. (1999). 52-week oral gavage chronic toxicity study with ubiquinone in rats with a 4-week recovery. J Agric Food Chem 47, 3756–63.
44. Xu X. Brining D. Rafiq A. Hayes J. Chen J. D. (2005). Effects of enhanced viscosity on canine gastric and intestinal motility. J Gastroenterol Hepatol 20, 387–94.